EP PerMed is organising a Call Information Day on 3 December 2026 from 15:00 to 17:00 CET for the EP PerMed JTC2027 ‘Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)’.
© Igor / Marina – stock.adobe.com | adapted
Registration for the Call Information Day will be available soon!
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapy (CGT) for personalised medicine (PM) approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
- Somatic cell therapeutics;
- Gene therapeutics;
- Combined cell- and gene therapeutics;
- Novel biological products such as mRNA, other nucleic acid-based methods, and extracellular vesicles as vehicle for gene-based therapeutic procedure.
Research projects in all disease areas are encouraged.
EP PerMed overall aims to:
- Encourage and enable interdisciplinary collaborations, i.e. multi-actor research, by engaging a range of relevant disciplines such as pre-clinical and clinical research, bioinformatics/health informatics/data research, ELSA research, implementation research or health economics research connected to the proposed research topic, including end-user perspective analysis to facilitate the implementation of PM;
- Encourage cross-sectorial collaborations, by including the private sector (e.g. SMEs, small and medium-sized enterprises, industry), as well as regulatory/HTA (health technology assessment) agencies and patient organisations.
Expected timeline of the call
| Date | Event |
|---|---|
| 04 November 2026 | Publication of the call |
| 03 December 2026 | Information day |
| 20 January 2027 (14:00, CET) | Deadline for pre-proposal submission |
| Beginning of April 2027 | Communication of the results of the pre-proposal assessment and invitation to the full proposal stage |
| 25 May 2027 (14:00, CEST) | Deadline for full proposal submission |
| Beginning of August 2027 | Rebuttal stage |
| Expected for October 2027 | Communication of the funding decisions to the applicants |
| End of 2027 / beginning of 2028 | Expected project start (according to regional/national funding regulations) |